Literature DB >> 24075919

Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations.

Berran Yucesoy1, Yerkebulan Talzhanov, Victor J Johnson, Nevin W Wilson, Raymond E Biagini, Wei Wang, Bonnie Frye, David N Weissman, Dori R Germolec, Michael I Luster, Michael M Barmada.   

Abstract

The influence of genetic variability within the major histocompatibility complex (MHC) region on variations in immune responses to childhood vaccination was investigated. The study group consisted of 135 healthy infants who had been immunized with hepatitis B (HBV), 7-valent pneumococcal conjugate (PCV7), and diphtheria, tetanus, acellular pertussis (DTaP) vaccines according to standard childhood immunization schedules. Genotype analysis was performed on genomic DNA using Illumina Goldengate MHC panels (Mapping and Exon Centric). At the 1 year post vaccination check-up total, isotypic, and antigen-specific serum antibody levels were measured using multiplex immunoassays. A number of single nucleotide polymorphisms (SNPs) within MHC Class I and II genes were found to be associated with variations in the vaccine specific antibody responses and serum levels of immunoglobulins (IgG, IgM) and IgG isotypes (IgG1, IgG4) (all at p<0.001). Linkage disequilibrium patterns and functional annotations showed that significant SNPs were strongly correlated with other functional regulatory SNPs. These SNPs were found to regulate the expression of a group of genes involved in antigen processing and presentation including HLA-A, HLA-C, HLA-G, HLA-H, HLA-DRA, HLA-DRB1, HLA-DRB5, HLA-DQA1, HLA-DQB1, HLA-DOB, and TAP-2. The results suggest that genetic variations within particular MHC genes can influence immune response to common childhood vaccinations, which in turn may influence vaccine efficacy. Published by Elsevier Ltd.

Entities:  

Keywords:  CPS; Childhood vaccine; DTaP; Genetic polymorphism; HBV; HBsAg; HLA; Hib; IPV; Ig; Immune response; LD; MHC; Major histocompatibility complex; OR; PCV7; PnPS; SNP; diphtheria, tetanus, and pertussis; haemophilus influenza type b; hepatitis B virus; heptavalent pneumococcal conjugate; human leukocyte antigen; immunoglobulin; inactivated polio vaccine; linkage disequilibrium; major histocompatibility complex; odds ratio; pneumococcal cell wall polysaccharide; pneumococcal polysaccharides; single nucleotide polymorphism; surface antigen of hepatitis B virus

Mesh:

Substances:

Year:  2013        PMID: 24075919      PMCID: PMC4640212          DOI: 10.1016/j.vaccine.2013.09.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  46 in total

1.  Recommended childhood immunization schedule--United States, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-01-18       Impact factor: 17.586

2.  Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides.

Authors:  Raymond E Biagini; Sonela A Schlottmann; Deborah L Sammons; Jerome P Smith; John C Snawder; Cynthia A F Striley; Barbara A MacKenzie; David N Weissman
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 3.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 4.  The transporter associated with antigen processing: function and implications in human diseases.

Authors:  Brigitte Lankat-Buttgereit; Robert Tampé
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

5.  Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus.

Authors:  A De Silvestri; A Pasi; M Martinetti; C Belloni; C Tinelli; G Rondini; L Salvaneschi; M Cuccia
Journal:  Genes Immun       Date:  2001-11       Impact factor: 2.676

6.  IL-1beta gene polymorphisms influence hepatitis B vaccination.

Authors:  Berran Yucesoy; Annemarie Sleijffers; Michael Kashon; Johan Garssen; Frank R de Gruijl; Greet J Boland; Jan van Hattum; Petia P Simeonova; Michael I Luster; Henk van Loveren
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

Review 7.  Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.

Authors:  David Milich; T Jake Liang
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

Review 8.  Immunogenetics of the response to HBsAg vaccination.

Authors:  David R Milich; Geert G Leroux-Roels
Journal:  Autoimmun Rev       Date:  2003-09       Impact factor: 9.754

9.  Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.

Authors:  Raymond E Biagini; Deborah L Sammons; Jerome P Smith; Barbara A MacKenzie; Cynthia A F Striley; Vera Semenova; Evelen Steward-Clark; Karen Stamey; Alison E Freeman; Conrad P Quinn; John E Snawder
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

10.  The association of class I HLA alleles and antibody levels after a single dose of measles vaccine.

Authors:  Robert M Jacobson; Gregory A Poland; Robert A Vierkant; V Shane Pankratz; Daniel J Schaid; Steven J Jacobsen; Jennifer St Sauver; S Breanndan Moore
Journal:  Hum Immunol       Date:  2003-01       Impact factor: 2.850

View more
  23 in total

1.  A population response analysis approach to assign class II HLA-epitope restrictions.

Authors:  Sinu Paul; Myles B C Dillon; Cecilia S Lindestam Arlehamn; Huang Huang; Mark M Davis; Denise M McKinney; Thomas Jens Scriba; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2015-05-06       Impact factor: 5.422

2.  Changing face of vaccination in immunocompromised hosts.

Authors:  Daire O'Shea; Lukas A Widmer; Jörg Stelling; Adrian Egli
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

3.  Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Authors:  Enoch Muyanja; Aloysius Ssemaganda; Pearline Ngauv; Rafael Cubas; Helene Perrin; Divya Srinivasan; Glenda Canderan; Benton Lawson; Jakub Kopycinski; Amanda S Graham; Dawne K Rowe; Michaela J Smith; Sharon Isern; Scott Michael; Guido Silvestri; Thomas H Vanderford; Erika Castro; Giuseppe Pantaleo; Joel Singer; Jill Gillmour; Noah Kiwanuka; Annet Nanvubya; Claudia Schmidt; Josephine Birungi; Josephine Cox; Elias K Haddad; Pontiano Kaleebu; Patricia Fast; Rafick-Pierre Sekaly; Lydie Trautmann; Denis Gaucher
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

Review 4.  Recent Advances in Application of Pharmacogenomics for Biotherapeutics.

Authors:  Pramod B Mahajan
Journal:  AAPS J       Date:  2016-03-23       Impact factor: 4.009

5.  Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.

Authors:  Odilon Nouatin; Ulysse Ateba Ngoa; Javier Ibáñez; Jean Claude Dejon-Agobe; Benjamin Mordmüller; Jean Ronald Edoa; Fabrice Mougeni; Sina Brückner; Aurore Bouyoukou Hounkpatin; Meral Esen; Michael Theisen; Kabirou Moutairou; Stephen L Hoffman; Saadou Issifou; Adrian J F Luty; Marguerite M Loembe; Selidji Todagbé Agnandji; Bertrand Lell; Peter G Kremsner; Ayôla Akim Adegnika
Journal:  Vaccine       Date:  2020-05-05       Impact factor: 3.641

6.  A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.

Authors:  Sukumar Pal; Olga V Tatarenkova; Luis M de la Maza
Journal:  Immunology       Date:  2015-10-01       Impact factor: 7.397

7.  Lymph node fibrosis: a structural barrier to unleashing effective vaccine immunity.

Authors:  Boris Julg; Galit Alter
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

8.  Inadequate activation of the HBsAg-specific Th cells by APCs leads to hyporesponsiveness to HBsAg vaccine in B10.S mice.

Authors:  Xiaofei Li; Jing Xu; Zhihui Lv; Jing Wang; Shuhui Sun; Wei Zhu; Bin Wang; Rui He; Di Qu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Impaired Antigen-Specific Immune Response to Vaccines in Children with Antibody Production Defects.

Authors:  Aleksandra Szczawinska-Poplonyk; Anna Breborowicz; Husam Samara; Lidia Ossowska; Grzegorz Dworacki
Journal:  Clin Vaccine Immunol       Date:  2015-05-27

10.  Deltex1 Polymorphisms Are Associated with Hepatitis B Vaccination Non-Response in Southwest China.

Authors:  Bin Xie; Penghui Zhang; Menggang Liu; Wei Zeng; Juntao Yang; Hongming Liu
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.